Professor Peter Andrews disusses his involvement with the Eurotherm 3235 Trial. The Eurotherm3235Trial is an international, multi-centre, randomised controlled trial which will examine the effects of titrated therapeutic hypothermia (32-35°C) as a treatment for raised intracranial pressure after traumatic brain injury.
http://www.ed.ac.uk/clinical-sciences/divisionpgdi/anaesthesia